Cel-Sci Corp Series S
CVM.WS
CVM.WS was delisted on the 8th of October, 2018.
3 hedge funds and large institutions have $185K invested in Cel-Sci Corp Series S in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 5 closing their positions.
172% more capital invested
Capital invested by funds: $68K → $185K (+$117K)
50% less funds holding
Funds holding: 6 → 3 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$6.26K |
| 2 |
VF
Virtu Financial
New York
|
+$813 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$37K |
| 2 |
TCM
Tenor Capital Management
New York
|
-$19K |
| 3 |
Millennium Management
New York
|
-$10K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1K |
CVM.WS Hedge Fund Activity: Q2 2018 in Review
3 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Cel-Sci Corp Series S (CVM.WS) for Q2 2018, worth a combined $185K — up 172% from $68K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CVM.WS and 2 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was DZ Bank, opening a new position worth an estimated $6.26K. The largest seller was Park West Asset Management, exiting entirely with an estimated $37K sold.
- 3 institutional investors held Cel-Sci Corp Series S (CVM.WS) as of Q2 2018, down from 6 in Q1 2018.
- Funds reported $185K of Cel-Sci Corp Series S stock for Q2 2018, up 172% quarter-over-quarter.
- 2 funds opened new Cel-Sci Corp Series S positions in Q2 2018 and 5 closed out, a net change of -3 holders.
- The largest Cel-Sci Corp Series S buyer in Q2 2018 was DZ Bank, an estimated $6.26K added.
- The largest Cel-Sci Corp Series S seller in Q2 2018 was Park West Asset Management, an estimated $37K sold.
Based on aggregated 13F filings for Q2 2018.